Skip to content

Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)

Combined Intensive and Conventional Exercise Intervention of Nonalcoholic Fatty Liver Disease

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01418027
Enrollment
220
Registered
2011-08-16
Start date
2011-08-31
Completion date
2013-12-31
Last updated
2014-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)

Keywords

NAFLD, exercise, hepatic triglycerides

Brief summary

The prevalence of NAFLD is 50-70% in obese people. A decrease of calorie intake and increase of physical activity are recommended as an effective approach for the prevention and treatment of NAFLD. However, the exercise model for NAFLD intervention is understudied. In the present study we aim to compare the effect of intensive and conventional exercise interventions on NAFLD.

Interventions

Subjects conduct an aerobic exercise at 65-80% maximum oxygen consumption for 30 minutes each day, five days a week, totally for 6 months.Subsequently, moderate physical activity(3.0-6.0 MET s) at 150 min/wk for 6 months.

OTHERConventional exercise

Subjects receive moderate physical activity(3.0-6.0 MET s) at 150 min/wk(30 min per day, five days a week) for 12 months.

Sponsors

Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects with NAFLD determined by MRS ; 2. Age 40-65 years old; 3. Waist circumference\> 90cm for men and \> 85cm for women.

Design outcomes

Primary

MeasureTime frame
Change of intrahepatic triglyceride contents12 months

Secondary

MeasureTime frame
Change of waist circumference12 months
Change of body fat12 months
Change of abdominal fat12 montshs
Change of body weight12 months
Change of cardiovascular risk factors (Blood pressure, lipids, glucose)12 months
Change of insulin resistance12 months
Change of carotid intima-media thickness12 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026